135 related articles for article (PubMed ID: 21903092)
21. Resistance to endoplasmic reticulum stress is an acquired cellular characteristic of rheumatoid synovial cells.
Yamasaki S; Yagishita N; Tsuchimochi K; Kato Y; Sasaki T; Amano T; Beppu M; Aoki H; Nakamura H; Nishioka K; Nakajima T
Int J Mol Med; 2006 Jul; 18(1):113-7. PubMed ID: 16786162
[TBL] [Abstract][Full Text] [Related]
22. RING finger protein 31 promotes p53 degradation in breast cancer cells.
Zhu J; Zhao C; Zhuang T; Jonsson P; Sinha I; Williams C; Strömblad S; Dahlman-Wright K
Oncogene; 2016 Apr; 35(15):1955-64. PubMed ID: 26148235
[TBL] [Abstract][Full Text] [Related]
23. Cisplatin-induced non-apoptotic death of pancreatic cancer cells requires mitochondrial cyclophilin-D-p53 signaling.
Chen B; Xu M; Zhang H; Wang JX; Zheng P; Gong L; Wu GJ; Dai T
Biochem Biophys Res Commun; 2013 Aug; 437(4):526-31. PubMed ID: 23845906
[TBL] [Abstract][Full Text] [Related]
24. CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene.
Liu YC; Chang PY; Chao CC
Nucleic Acids Res; 2015 Dec; 43(22):10760-81. PubMed ID: 26384430
[TBL] [Abstract][Full Text] [Related]
25. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase.
DeHaan RD; Yazlovitskaya EM; Persons DL
Cancer Chemother Pharmacol; 2001 Nov; 48(5):383-8. PubMed ID: 11761456
[TBL] [Abstract][Full Text] [Related]
26. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
[TBL] [Abstract][Full Text] [Related]
27. Synoviolin inhibitor LS-102 reduces endoplasmic reticulum stress-induced collagen secretion in an in vitro model of stress-related interstitial pneumonia.
Nakajima F; Aratani S; Fujita H; Yagishita N; Ichinose S; Makita K; Setoguchi Y; Nakajima T
Int J Mol Med; 2015 Jan; 35(1):110-6. PubMed ID: 25351210
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
29. Hyper-O-GlcNAcylation induces cisplatin resistance via regulation of p53 and c-Myc in human lung carcinoma.
Luanpitpong S; Angsutararux P; Samart P; Chanthra N; Chanvorachote P; Issaragrisil S
Sci Rep; 2017 Sep; 7(1):10607. PubMed ID: 28878262
[TBL] [Abstract][Full Text] [Related]
30. Pellino-1 confers chemoresistance in lung cancer cells by upregulating cIAP2 through Lys63-mediated polyubiquitination.
Jeon YK; Kim CK; Koh J; Chung DH; Ha GH
Oncotarget; 2016 Jul; 7(27):41811-41824. PubMed ID: 27248820
[TBL] [Abstract][Full Text] [Related]
31. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells.
Chan DW; Liu VW; Tsao GS; Yao KM; Furukawa T; Chan KK; Ngan HY
Carcinogenesis; 2008 Sep; 29(9):1742-50. PubMed ID: 18632752
[TBL] [Abstract][Full Text] [Related]
32. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells.
Tan S; Hougardy BM; Meersma GJ; Schaap B; de Vries EG; van der Zee AG; de Jong S
Mol Pharmacol; 2012 May; 81(5):701-9. PubMed ID: 22328720
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells.
Abedini MR; Muller EJ; Brun J; Bergeron R; Gray DA; Tsang BK
Cancer Res; 2008 Jun; 68(12):4511-7. PubMed ID: 18559494
[TBL] [Abstract][Full Text] [Related]
34. An E3 ubiquitin ligase, Synoviolin, is involved in the degradation of immature nicastrin, and regulates the production of amyloid beta-protein.
Maeda T; Marutani T; Zou K; Araki W; Tanabe C; Yagishita N; Yamano Y; Amano T; Michikawa M; Nakajima T; Komano H
FEBS J; 2009 Oct; 276(20):5832-40. PubMed ID: 19725872
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of hyaluronan binding protein 1 (HABP1/p32/gC1qR) is associated with Cisplatin induced apoptosis.
Kamal A; Datta K
Apoptosis; 2006 May; 11(5):861-74. PubMed ID: 16544101
[TBL] [Abstract][Full Text] [Related]
36. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
[TBL] [Abstract][Full Text] [Related]
37. A novel RING finger E3 ligase RNF186 regulate ER stress-mediated apoptosis through interaction with BNip1.
Wang P; Wu Y; Li Y; Zheng J; Tang J
Cell Signal; 2013 Nov; 25(11):2320-33. PubMed ID: 23896122
[TBL] [Abstract][Full Text] [Related]
38. Aurora-A promotes gefitinib resistance via a NF-κB signaling pathway in p53 knockdown lung cancer cells.
Wu CC; Yu CT; Chang GC; Lai JM; Hsu SL
Biochem Biophys Res Commun; 2011 Feb; 405(2):168-72. PubMed ID: 21216229
[TBL] [Abstract][Full Text] [Related]
39. Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells.
Chen YL; Lin PC; Chen SP; Lin CC; Tsai NM; Cheng YL; Chang WL; Lin SZ; Harn HJ
J Pharmacol Exp Ther; 2007 Nov; 323(2):746-56. PubMed ID: 17715378
[TBL] [Abstract][Full Text] [Related]
40. Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells.
Wu ZZ; Lu HP; Chao CC
Biochem Pharmacol; 2010 Jul; 80(2):262-76. PubMed ID: 20361941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
